Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
04/2003
04/10/2003US20030069309 Antiinflammatory agents; analgesics; antipyretics
04/10/2003US20030069297 4-aryl substituted indolinones
04/10/2003US20030069294 Alpha-substituted carboxylic acid derivatives
04/10/2003US20030069292 Central nervous system disorders; anticonvulsants
04/10/2003US20030069288 Substituted aminomethyl-phenyl-cyclohexane derivatives
04/10/2003US20030069287 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors
04/10/2003US20030069260 1-alkyl or 1-cycloalkyltriazolo[4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors
04/10/2003US20030069255 Pharmaceutical compositions for the coordinated delivery of NSAIDs
04/10/2003US20030069249 Analgesics; central nervous system disorders
04/10/2003US20030069248 Antiinflammatory agents; controlling cell cycle
04/10/2003US20030069246 Central nervous system disorders; psychological disorders; cardiovascular disorders
04/10/2003US20030069243 Novel substituted imidazole compounds
04/10/2003US20030069241 Analgesics; central nervous system disorders; gastrointestinal disorder; therapy for drug abruse ; antiinflammatory agents
04/10/2003US20030069238 Anticancer agents; immunology diseases; antiallergens; antiinflammatory agents
04/10/2003US20030069228 Capase inhibitors; antiinflammatory agents
04/10/2003US20030069210 Especially imidazolyl- or 1,2,4-triazolyl- pyrimidine derivatives
04/10/2003US20030069202 Compositions, kits, and methods for promoting defined health benefits
04/10/2003US20030069181 Alternative splice forms of proteins as basis for multiple therapeutic modalities
04/10/2003US20030069169 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-AMP associated disorders
04/10/2003US20030068387 Carbon monoxide generating compounds for treatment of vascular, inflammatory and immune disorders
04/10/2003US20030068367 Systems, methods and apparatuses for manufacturing dosage forms
04/10/2003US20030068331 Dressing for treatment of a dermatological disease comprised of a gum resin, a topically acceptable volatile solvent, and a pharmacologically active agent
04/10/2003US20030068320 Methods of administering/dosing CD2 antagonists for the prevention and treatment of autoimmune disorders or inflammatory disorders
04/10/2003CA2462795A1 Secreted proteins
04/10/2003CA2462661A1 A method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same
04/10/2003CA2462112A1 Spiro-hydantoin compounds useful as anti-inflammatory agents
04/10/2003CA2462004A1 Systems, methods and apparatuses for manufacturing dosage forms
04/10/2003CA2461670A1 Indole derivatives as cox ii inhibitors
04/10/2003CA2461618A1 Ibuprofen salt emulsifiers and cream formulations containing same
04/10/2003CA2461034A1 Tetrahydroisochinolines, their production and the use thereof as analgesics
04/10/2003CA2460917A1 Human tissue factor antibodies
04/10/2003CA2460916A1 Methods and compositions for modulating interleukin-21 receptor activity
04/10/2003CA2459825A1 Compounds useful as reversible inhibitors of cysteine proteases
04/10/2003CA2457798A1 Process for preparing heterocyclo-alkylsulfonyl pyrazole derivatives
04/09/2003EP1300411A1 Novel disaccharides with anti-arthritic action
04/09/2003EP1300401A1 Five-membered-ring compound
04/09/2003EP1300399A1 Phenylpyridazine derivatives and drugs containing the same
04/09/2003EP1300153A1 Use of n-desulfated heparin for treating or preventing inflammations
04/09/2003EP1300148A2 Use of bismuth subgallate in inhibition of production of nitric oxide synthase
04/09/2003EP1300143A1 Patch containing 4-biphenylacetic acid
04/09/2003EP1300138A2 Agents effective against hyperreactive and hypoactive deficient skin conditions as well as manifest dermatitis
04/09/2003EP1299548A1 Novel therapeutic molecular variants and uses thereof
04/09/2003EP1299546A2 Aminoacyl trna synthetases
04/09/2003EP1299545A2 Drug metabolizing enzymes
04/09/2003EP1299542A2 Non-agonistic antibodies to human gp39, compositions containing, and therapeutic use thereof
04/09/2003EP1299538A2 Secreted proteins
04/09/2003EP1299534A2 Grf2-binding proteins and applications thereof
04/09/2003EP1299533A2 Antisense oligonucleotides to inhibit angiogenesis and/or metastasis
04/09/2003EP1299430A2 Process for preparing benzoxazin-4-one polymer conjugates
04/09/2003EP1299421A2 Antibodies to human mcp-1
04/09/2003EP1299415A1 Chemokine receptor modulators, production and use
04/09/2003EP1299412A2 Protein modification and maintenance molecules
04/09/2003EP1299409A2 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-beta-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group
04/09/2003EP1299406A1 Curcumin derivatives with improved water solubility compared to curcumin and medicaments containing the same
04/09/2003EP1299392A2 Glucocortiocoid-selective antiinflammatory agents
04/09/2003EP1299385A2 Fused cyclic modulators of nuclear hormone receptor function
04/09/2003EP1299379A2 Lactam metalloprotease inhibitors
04/09/2003EP1299378A1 Tetrahydropyridino or piperidino heterocyclic derivatives
04/09/2003EP1299377A2 Spla2 inhibitors
04/09/2003EP1299374A1 Novel non-psychotropic cannabinoids
04/09/2003EP1299373A1 Cyclic substituted aminomethyl compounds and medicaments containing said compounds
04/09/2003EP1299372A1 Pyrones as inhibitors of cyclooxygenase-2
04/09/2003EP1299357A1 Novel compounds
04/09/2003EP1299356A1 Novel compounds
04/09/2003EP1299355A2 (2-oxindol-3-ylidenyl)acetic acid derivatives and their use as protein kinase inhibitors
04/09/2003EP1299351A1 Novel aryl, alkenyl, and alkynl 4-dedimethylaminotetracycline derivatives
04/09/2003EP1299350A1 Substituted benzamides for immune enhancement and for the treatment of cancer, infection and manic-depressive illness
04/09/2003EP1299157A1 Composition and applicator for topical substance delivery
04/09/2003EP1299123A2 Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders
04/09/2003EP1299122A2 Combination of a cox-2 inhibitor and a vasomodulator for treating pain and headache pain
04/09/2003EP1299107A2 Highly concentrated stable meloxicam solutions
04/09/2003EP1299089A2 Drug delivery system for poorly water soluble drugs
04/09/2003EP1299081A1 Use of oligosaccharides to stimulate beta-endorphin production
04/09/2003EP1299032A1 DNA encoding human serine protease D-G
04/09/2003EP1299010A1 Vitamin k and essential fatty acids
04/09/2003EP1220844B1 Aryl sulfonamide-substituted benzimidazol derivatives thereof as tryptase inhibitors
04/09/2003EP1023301B1 A heterocyclic chemical compound
04/09/2003EP1001766B1 Compounds for the treatment of ccr5-mediated diseases
04/09/2003EP0963197A4 Guanylhydrazones useful for treating diseases associated with t cell activation
04/09/2003EP0934280B1 Pde iv inhibiting 2-cyanoiminoimidazole derivatives
04/09/2003EP0928200B1 Therapeutic combinations of rar antagonists and rxr agonists
04/09/2003EP0918746B1 Immunotherapeutic agents and their use in the reduction of cytokine levels
04/09/2003EP0904272B1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
04/09/2003EP0874808B1 Biphenyl hydroxamate inhibitors of matrix metalloproteinases
04/09/2003EP0708768B1 Tri-substituted imidazoles having multiple therapeutic properties
04/09/2003EP0675956B1 New protein from urine named component b
04/09/2003CN1409726A Type I cytokine receptor TCCR
04/09/2003CN1409724A 雌二醇轭合物和其用途 Estradiol conjugates and uses thereof
04/09/2003CN1409716A New amino propylphosphinic acid
04/09/2003CN1409715A Cyclopenteneone derivatives
04/09/2003CN1409712A Pyrrolo [2,3-d] pyrimidine compounds
04/09/2003CN1409708A 酪氨酸激酶抑制剂 Tyrosine kinase inhibitor
04/09/2003CN1409639A TNF-alpha antagonist and LFA-1 antagonist for treating LFA-1 or TNF-alpha mediated disorder
04/09/2003CN1409635A Treatment of systemic lupus erythematosus with dehydroepiandrosterone
04/09/2003CN1409632A Use of retigabin for treating neuropathic pain
04/09/2003CN1409605A Method for increasing pet activity
04/09/2003CN1408714A Novel oripavine derivative and its medical use
04/09/2003CN1408703A New phenyl ethyl amine compounds having beta 2-receptor excitation and its producing method
04/09/2003CN1408437A Microcapsule adrenomedullary cell for curing malignant, tumor pain and its preparing method
04/09/2003CN1408416A Chinese medicine sichuan chinaberry plaster for relieving pain and its preparing method
1 ... 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 ... 1272